Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

CAN (BC): Grower receives Health Canada approval to expand production facility

Geyser Brands's licensed producer, Apothecary Botanicals, has received Health Canada license amendment approval to update its 7,000-square-foot facility located in Port Coquitlam, British Columbia.

"This expansion, anticipated to be complete by the end of June 2019, would allow for research and development and processing capabilities in anticipation of receiving its licensed amendments," the team with the company explains. "GYSR’s R&D license is pending Health Canada’s approval of the LP facility, though the company’s facility was recently audited by Health Canada and found to be fully compliant." "We hope to enhance our long-term success through attaining a processing license, which Geyser Brands believes will help it capitalize in the CBD wellness product market that’s predicted to be a multibillion-dollar industry."

The company’s facility expansion is anticipated to include mothering and cloning rooms, along with designated areas for working with approved seed banks. A focus on processing quality will allow Geyser Brands to ensure high-CBD seed strains with consistent cannabinoid profiles, providing a reliable quality experience for consumers via its products.

Additionally, Geyser Brands recently recognized an achievement of its acquisition target, Solace Management Group GMP-compliant Solace is now in its new manufacturing facility, which is located in Coquitlam, British Columbia.

"Solace hosts a dynamic portfolio of both pet and consumer health care goods, and the new facility adds to its focus on processing quality," they say. "The 7,500-square-foot construction increases production capacity by up to tenfold and allows Solace to “develop and license new products that are either ready for production or are in various stages of development.”

According to them, in an effort to partially or fully automate processes, new equipment has also been added to the facility, including an industrial oven, advanced blending and mixing systems, rotary depositing, large-volume kettle blending, a tincture mottling system and vertical-form-fill packaging. 

In 2018, the Global Wellness Institute estimated that the global wellness economy was a $4.2 trillion market that has shown growth in recent years. The teams at Geyser Brands and Solace realize the industry’s demand for product innovation and consumer satisfaction. Together, they aim to provide healthy and relevant products to a burgeoning consumer base.

For more information:
Geyser Brands
geyserbrands.com  

Publication date: